Skip to main content
Journal cover image

Understanding patient compliance and persistence with osteoporosis therapy.

Publication ,  Journal Article
Gold, DT
Published in: Drugs Aging
April 1, 2011

Chronic non-terminal diseases, including postmenopausal osteoporosis, are associated with poor treatment compliance and persistence. The longer a patient with osteoporosis complies and persists with treatment, the lower the risk of fracture. Retrospective studies with emphasis on real-world data have led to a greater understanding of the factors affecting medication compliance and persistence, and their association with improved treatment outcomes. However, these data do not contain information about patient choices of medication or patient commitment to particular medication regimens. Patient preferences can affect compliance and persistence behaviours. While recent evidence questions the importance of dosing regimen in patient preferences, other recent data show that medication efficacy and safety remain the most important determinants of patient preference. Informed patient decision making about treatment options, adverse effects and outcomes can have a beneficial impact on medication-taking behaviour. Healthcare professionals play a crucial role in the management of factors associated with poor compliance and persistence with osteoporosis therapies. Education about disease consequences and differences among treatment options, as well as treatment monitoring and positive reinforcement, are crucial to improving medication compliance and persistence in osteoporotic patients.

Duke Scholars

Published In

Drugs Aging

DOI

EISSN

1179-1969

Publication Date

April 1, 2011

Volume

28

Issue

4

Start / End Page

249 / 255

Location

New Zealand

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Postmenopause
  • Patient Satisfaction
  • Patient Compliance
  • Osteoporosis, Postmenopausal
  • Osteoporosis
  • Middle Aged
  • Humans
  • Geriatrics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gold, D. T. (2011). Understanding patient compliance and persistence with osteoporosis therapy. Drugs Aging, 28(4), 249–255. https://doi.org/10.2165/11586880-000000000-00000
Gold, Deborah T. “Understanding patient compliance and persistence with osteoporosis therapy.Drugs Aging 28, no. 4 (April 1, 2011): 249–55. https://doi.org/10.2165/11586880-000000000-00000.
Gold, Deborah T. “Understanding patient compliance and persistence with osteoporosis therapy.Drugs Aging, vol. 28, no. 4, Apr. 2011, pp. 249–55. Pubmed, doi:10.2165/11586880-000000000-00000.
Gold DT. Understanding patient compliance and persistence with osteoporosis therapy. Drugs Aging. 2011 Apr 1;28(4):249–255.
Journal cover image

Published In

Drugs Aging

DOI

EISSN

1179-1969

Publication Date

April 1, 2011

Volume

28

Issue

4

Start / End Page

249 / 255

Location

New Zealand

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Postmenopause
  • Patient Satisfaction
  • Patient Compliance
  • Osteoporosis, Postmenopausal
  • Osteoporosis
  • Middle Aged
  • Humans
  • Geriatrics